Navigation Links
Herley Industries, Inc. Reports Third Quarter Earnings
Date:6/11/2009

Portion of Employment Settlement Agreement - (net of imputed interest of $254 at May 3, 2009 and $387 at August 3, 2008) 2,243 3,074 Long-term Portion of litigation settlement - (net of imputed interest of $108 at August 3, 2008) - 892 Other Long-term Liabilities 2,126 1,652 Deferred Income Taxes 13,936 8,839 Accrued Income Taxes Payable 516 509 -------- -------- Total Liabilities 80,854 65,983 -------- -------- Commitments and Contingencies Shareholders' Equity: Common stock, $.10 par value; authorized 20,000,000 shares; issued and outstanding 13,559,427 at May 3, 2009, and 13,521,902 at August 3, 2008 1,356 1,352 Additional paid-in capital 102,231 101,403 Retained earnings 92,295 89,058 Accumulated other comprehensive (loss) income (593) 1,622 -------- -------- Total Shareholders' Equity 195,289 193,435 -------- -------- Total Liabilities and Shareholders' Equity $276,143 $259,418 -------- -------- 


                     HERLEY INDUSTRIES, INC. AND SUBSIDIARIES
            CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
              
'/>"/>
SOURCE  Herley Industries, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 

Related medicine news :

1. Herley Reports 4th Quarter and Year-End Results
2. Herley Industries, Inc. Receives a $5 Million Award from EDO for Electronic Components for IEDs
3. Herley Industries Announces the Passing of Its Former President
4. Herley Industries, Inc. Second Quarter Earnings Release and Conference Call Notice
5. Herley Reports Second Quarter Results
6. Herley Awarded $1 Million in Awards for Integrated Microwave Assemblies for U.S. Military Aircraft
7. Herley Announces Settlement Agreement with U.S. Government
8. Herley Reports Third Quarter Results
9. Herley Industries, Inc. Engages Jefferies Quarterdeck to Explore Strategic Alternatives
10. Herley New England Receives Additional $1.3 Million Contract Award from Lockheed Martin for the Multi-Mission Helicopter
11. Herley Industries, Inc. First Quarter Earnings Release and Conference Call Notice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...earchers have found evidence of a statistically si... among patients whose estrogen receptor (ER)-posit...R-alpha; at serine-118 (ER-alpha S118-P), accordin...er 25 in the Journal of the National Cancer Insti...are resistant to tamoxifen. Preclinical studies ha...
(Date:11/25/2009)...tudy follow-up period was too short to draw defini...DAY, Nov. 25 (HealthDay News) -- In diabetic patie...to be no difference in outcomes at one year whethe...ith stenting, British researchers report. , Byp...abetic patients with coronary artery disease. Howe...
(Date:11/25/2009)...ue, forgetfulness could lead mothers to overlook n...ov. 25 (HealthDay News) -- A mother,s depression c...e found. , Their six-month study of 262 black m...e mothers had more depressive symptoms had more fr...with fewer depressive symptoms had less frequent a...
(Date:11/25/2009)..., NEWYORK,Nov.25/PRNewswire/-- MISSIONSkincare &#...illionforSt.Jude.AspartofGNC,sannualSt.Jude Thanks...ISSIONSkincare,s new SUPER-C(TM)LipBalm willbedo...ortunitytomakea$1,$5or$10donationatcheckoutatoneof...isemorethan$1millionforSt.Judeduringtheir2009 Than...
(Date:11/25/2009)...BRIDGE, Mass. -- A cancer vaccine carried into the...implant is the first to successfully eliminate tum... journal Science Translational Medicine . , The...ologists at Harvard University, uses plastic disks...anted under the skin to reprogram the mammalian im...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Mom's Depression May Worsen Child's Asthma 2Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
... the area behind your last tooth is swollen and te... leads you nice and early to knock the doors of yo... your wisdom tooth that is trying to tear your gum... removed and that too one which has not yet erupte...
...butor in the plant kingdom among pulses. Besides p...n it is also known to have numerous other health b...n to lower cholesterol, slow the development of di...e a reason to cheer about! Soy protein has been...
...creased the risk of death from coronary heart dise...erable to heart disease and lung cancer compared t...which was published in the British Medical Journal...e likely to be affected by the habit. Light smoker...
...alth threat. One method of reducing the incidence ... so called BCG vaccine. // Although more than 3...stered to fight tuberculosis, the ability of the B...ategy to enhance the immunogenicity of BCG has bee...
...butor in the plant kingdom among pulses. Besides p...n it is also known to have numerous other health b...own to lower cholesterol, slow the development of ...ave a reason to cheer about! Soy protein has ...
... Health Letter had published a report on a new way...s. According to the Harvard Mental Health Let...ay so far to predict whether healthy elderly peopl...r’s over the next 10 years. Brain scans may also p...
Other Medicine News:
(Date:11/25/2009)...MINGHAM,Mass.andSYDNEY,Nov.25/PRNewswire-FirstCall...IN),aleadinginnovatorandprovideroflessinvasive,min...zingthetreatmentofadvancedheartfailure,todayannoun...the21stAnnualPiperJaffrayHealthCareConferenceat8:0...ingheldattheNewYorkPalaceHotel,December1-2. ,, ...
(Date:11/24/2009)...HESDA,Md.,Nov.24/PRNewswire-Asia/--ChindexInternat...pendentAmericanproviderofWestern,healthcareproduct...ouncedthattheCompanywillattendthe21stAnnualPiperJa...mber1-2,2009,atthe,NewYorkPalaceHotel. , Mana...esday,December1,2009,andholdone-on-onemeetingsthr...
(Date:11/24/2009)...INE,Calif.,Nov.24/PRNewswire-FirstCall/--Endologix...reatmentsforaorticdisorders,announcedtodaythatitha...thepatentinfringementlawsuitbroughtagainstitinOcto...esDistrictCourtinIndianapolis,Indiana. ,, Endol...nitedStatesPatentandTrademarkOffice(USPTO)conducts...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2The Leapfrog Group Announces New Board Chair 50087 1The Leapfrog Group Announces New Board Chair 50087 2The Leapfrog Group Announces New Board Chair 50087 3Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 1Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 2Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 3Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 4Supply of Key Childrens Vaccine Almost Back to Normal 50081 1Supply of Key Childrens Vaccine Almost Back to Normal 50081 2Supply of Key Childrens Vaccine Almost Back to Normal 50081 3
...NESS WIRE)--May 17, 2007 - Results,published this ...er,vaccine, GARDASIL (Quadrivalent Human Papilloma...as 100 percent effective in,preventing high-grade ...16 and 18, two types strongly associated with thes...d in women who were not,infected with HPV types ta...
...th International Symposium on,Myelodysplastic Synd...ew updated results,from a pivotal Phase II trial e...lood cancer known as myelodysplastic syndromes (MD... H. Lee Moffitt,Cancer Center & Research Insti...rrently taking place in Florence, Italy.,Breakthro...
Other Medicine Technology:Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 2Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 3Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 4Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 5Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 6Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 7Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 8Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 9Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 10Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 11Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 12Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 13Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 14Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 15Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 16Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 17Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 18Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 19Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 20Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 21Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 22Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 23Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 24Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 25Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 26Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 27Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 28Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 29Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 30Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 31Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 32Study Continues to Show Patients With Myelodysplastic Syndromes,Treated With Revlimid are Living Longer and Remaining Transfusion,Independent 2Study Continues to Show Patients With Myelodysplastic Syndromes,Treated With Revlimid are Living Longer and Remaining Transfusion,Independent 3
...higher risk diabetic patient, the PneumaticWalker ...iabetics. Similar to the PneumaticWalker, the Pneu...ve dual density insole to eliminate pressure point...shell and full aircell coverage, also helps regula...
...ce is designed for the treatment of diaphyseal fra...rovides post operative support following intra m...al fixation. The brace allows for movement of join...ascularity and encouraging bone growth. For a more...
...tem for the treatment of injuries of the lower leg...forms to the patient's anatomy and in conjunction ...ilization. As the general time of fracture or rupt...es of treatment can be altered significantly. Exce...
...nefits of controlled compression to minimize hemar...he cuff is anatomically designed to completely fit...o/Cuffs can be ordered as a single cuff, or with a...disk). The Cooler is available separately and can ...
Medicine Products: